All News

FDA Greenlights Low-Dose Clorthalidone (12.5 mg) for Treatment of Hypertension in Adults
May 08, 2025

Low-dose clorthalidone offers clinicians a new option for initiating treatment that may mitigate well-known metabolic adverse effects.

GLP-1 Agonists May Preserve Muscle Mass During Weight Loss: Daily Dose
May 08, 2025

Your daily dose of the clinical news you may have missed.

Roflumilast Foam 0.3% Update: Pivotal Phase 3 Trial Outcomes Published in JAMA Dermatology, Arcutis Announces
May 08, 2025

Publication of the phase 3 ARRECTOR trial findings precede an anticipated PDUFA date of May 22, 2025, for the investigational foam, now under FDA review.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians
May 07, 2025

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Machine Learning Model Effectively Predicts Depression Risk in Adults with COPD
May 07, 2025

The model demonstrated 70.63% accuracy for predicting depression, a common comorbidity seen in COPD and one that increases risk for negative outcomes.

Topical PDE4 Inhibitor ZORYVE® (Roflumilast) Cream for the Treatment of Atopic Dermatitis
May 07, 2025

ZORYVE® (roflumilast) cream 0.15% is a once-daily, steroid-free PDE4 inhibitor approved for the treatment of mild to moderate atopic dermatitis in patients aged 6 and older. Clinical trials demonstrate its rapid onset, strong efficacy, and favorable safety profile, with emerging evidence supporting its use in younger children and as a long-term maintenance therapy to prevent flares.

Investigational GPR119 Agonist Shows Dual Hepatoprotective and Glycemic Benefits in MASH Patients
May 07, 2025

EASL 2025. DA-1241 significantly reduced plasma ALT levels, improved systemic inflammatory and fibrosis biomarkers, according to drug developer MetaVia.

Cervical Cancer Screening: What Physicians Can Do To Convince Patients
May 07, 2025

An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.

Physician Survey: Assessing Cognitive Decline in Primary Care
May 07, 2025

Primary care clinicians are on the frontline of detecting early cognitive decline. Help us understand your challenges by taking this short survey.

Study Finds 40% of Research Participants Decline to Learn Results of Alzheimer Disease Biomarker Testing
May 07, 2025

The new findings are contrary to previous research that found family history of AD increases desire for testing and support the "right not to know."